Patent · US Active

Combination therapies for treating type 1 diabetes

US8758761B2 · kind B2 · utility

1Cited by

17References

16Claims

0Family size

Assignees

University of Florida Research Foundation, INC. · US
Genzyme Corporation · US

Inventors

Mark A. Atkinson · Gainesville, US
Scott Eisenbeis · Lowell, US
Donna Armentano · Belmont, US
Abraham Scaria · Framingham, US
Tracey Lodie · Northbridge, US

Key dates

Filing date	Sep 30, 2008
Grant date	Jun 24, 2014
Priority date	—
Expiry date	Dec 16, 2029

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P37/06
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

In accordance with the subject invention, combination therapies can be used to modulate a patient's immune response in order to prevent, delay and/or reverse type 1 diabetes.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.